Crossmark

Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Published Online: 2020-05-01

Published Print: 2020-12

Authors

Perez Kerkvliet, Carlos

Dwyer, Amy R.

Diep, Caroline H.

Oakley, Robert H.

Liddle, Christopher

Cidlowski, John A.

Lange, Carol A.
Funding

Funding for this research was provided by:

National Institute of Health (R01 CA192178, T32 CA009138, T32 GM008244, F30 CA228261, UL1TR002494, UL1TR002494, ES090057)
License Information

Text and Data Mining valid from 2020-05-01

Version of Record valid from 2020-05-01
More Information

Article History

Received: 1 October 2019

Accepted: 7 April 2020

First Online: 1 May 2020

Ethics approval and consent to participate

: All human mRNA data that was used for this research article is publicly available via GEO, GDC, and cBioPortal.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current